FDA targets cancer drugs to be less toxic, more cost effective

FDA urges drug companies to reassess cancer drug dosages for maximum impact and fewer side effects, following study on lung cancer drug

Related Keywords

Washington ,United States ,Mark Ratain ,Washington Post ,University Of Chicago ,Amgen ,Fda ,Drug Companies ,Cancer Drug ,Dosage ,Side Effects ,Lung Cancer ,Drug Trials ,Maximum Tolerated Dose ,Clinical Trials ,